Global Hepatitis B Vaccines Business Research Report 2024: Market to Reach $3.9 Billion by 2030 from $2.9 Billion in 2023 with Combination Vaccines Accounting for $2.6 Billion


Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Hepatitis B Vaccines Market to Reach $3.9 Billion by 2030

The global market for Hepatitis B Vaccines estimated at US$2.9 Billion in the year 2023, is projected to reach a revised size of US$3.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record 4.3% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Mono Vaccines segment is estimated at 3.1% CAGR for the next 8-year period.



The U.S. Market is Estimated at $781.1 Million, While China is Forecast to Grow at 6.2% CAGR

The Hepatitis B Vaccines market in the U.S. is estimated at US$781.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$832 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 3.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Key Attributes:

Report AttributeDetails
No. of Pages182
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$2.9 Billion
Forecasted Market Value (USD) by 2030$3.9 Billion
Compound Annual Growth Rate3.8%
Regions CoveredGlobal



MARKET OVERVIEW

  • Influencer Market Insights
  • Hepatitis B Vaccines - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Global Economic Update

FOCUS ON SELECT PLAYERS(Total 14 Featured)

  • Beijing Minhai Biotechnology Co., Ltd.
  • Bharat Biotech International Ltd.
  • Binnopharm Group LLC
  • Biokangtai
  • CSL Ltd.
  • Dynavax Technologies Corporation
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline PLC
  • Hualan Biological Engineering Co., Ltd.
  • Merck & Co., Inc.

For more information about this report visit https://www.researchandmarkets.com/r/kadkej

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Hepatitis B Vaccines Market

Contact Data